Trial Profile
Persistence of Antibodies After GSK Biologicals' Meningococcal Vaccine GSK134612 in Toddlers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Meningococcal vaccine group C conjugate
- Indications Meningococcal infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 12 Aug 2016 New trial record